MENU
JUNS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Jupiter Neurosciences (JUNS) Ownership - Who owns Jupiter Neurosciences?

Jupiter Neurosciences Inc is a clinical-stage research and development company focused on developing treatments for neuroinflammation through the resveratrol platform... Show more

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
11.09M
P/E Ratio
N/A
Total Cash
2.36M
Projected Growth
N/A
Total Debt
4.83M
Revenue
40.45K
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
0.05
Total Debt/Equity
N/A
Revenue/Share
0.00 USD as % of share price
View a ticker or compare two or three
JUNS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Details